Post-approval studies (Phase 4)Study completedNCT02590627
What this trial is testing
In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure
Who this might be right for
Malaria
National Institute for Medical Research, Tanzania 509